• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ICU MEDICAL DE MEXICO, S. DE R.L. DE C.V. 30" (76 CM) APPX 3.3 ML, 20 DROP ADMIN SET W/INTEGRATED CHEMOLOCK¿ DRIP CHAMBER,; CLOSED ANTINEOPLASTIC AND HAZARDOUS DRUG RECONSTITUTION AND TRANSFER SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ICU MEDICAL DE MEXICO, S. DE R.L. DE C.V. 30" (76 CM) APPX 3.3 ML, 20 DROP ADMIN SET W/INTEGRATED CHEMOLOCK¿ DRIP CHAMBER,; CLOSED ANTINEOPLASTIC AND HAZARDOUS DRUG RECONSTITUTION AND TRANSFER SYSTEM Back to Search Results
Catalog Number CL3011
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/24/2024
Type of Reportable Event Malfunction
Event or Problem Description
The event involved a 30" (76 cm) appx 3.3 ml, 20 drop admin set w/integrated chemolock¿ drip chamber, spiros® w/red cap, hanger where the customer reported that there was leakage from connection point between the spiros and the tubing.The customer stated that the tubing was failing or cracking.The issue was discovered during infusion.The set-up was then replaced and therapy resumed.There was patient involvement and no harm associated with the event.There were 7 incidents reported.
 
Additional Manufacturer Narrative
The device has been received for evaluation, however, investigation is not yet complete.
 
Additional Manufacturer Narrative
A series of photos were shared by the customer, where different photos show leaks inside the plastic bag and looks is looks coming from the spiros.No additional damage or anomalies are observed.Seven (7) used.List #cl3011 connected into a different used intravenous and 5% dextrose injection usp 500 ml excel bags were returned for evaluation.As received it was observed on samples #1 and #2, the o-ring was not seated correctly.Once each of the samples was primed at gravity pressure, a leak was observed coming from inside the spiros, except from sample #4.The complaint of leaks can be confirmed.The probable cause of the dislodged o-ring is unknown.The lot history was reviewed, no nonconformities were identified that may have contributed to the reported complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
30" (76 CM) APPX 3.3 ML, 20 DROP ADMIN SET W/INTEGRATED CHEMOLOCK¿ DRIP CHAMBER,
Common Device Name
CLOSED ANTINEOPLASTIC AND HAZARDOUS DRUG RECONSTITUTION AND TRANSFER SYSTEM
Manufacturer (Section D)
ICU MEDICAL DE MEXICO, S. DE R.L. DE C.V.
avenida cuarzo no. 250
ensenada, b.cfa. 22790
MX  22790
Manufacturer Contact
reed covert
600 n. field dr.
lake forest, IL 60045
2247062300
MDR Report Key19377553
Report Number9617594-2024-00641
Device Sequence Number20752697
Product Code ONB
UDI-Device Identifier00887709057012
UDI-Public(01)00887709057012(17)290201(10)13894020
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K131549
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 07/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberCL3011
Device Lot Number13894020
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/07/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/24/2024
Supplement Date Received by Manufacturer06/27/2024
Initial Report FDA Received Date05/22/2024
Supplement Report FDA Received Date07/22/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/01/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-